VION Biosciences Acquires Echelon Biosciences

Graphic-Business-Wire

VION Biosciences, a life science platform company focused on specialty reagents in the life science research, diagnostic, and drug discovery space, announced the recent acquisition of Salt Lake City-based Echelon Biosciences, a trusted supplier of critical materials, notably lipid-based excipients, to its growing portfolio. This acquisition serves as the second investment under VION Biosciences LLC […]

Sirnaomics and Gore Range Capital Partner to Launch Sagesse Bio, an Aesthetic Medicine Company

Sirnaomics Ltd., a leading biopharmaceutical company, and Gore Range Capital LLC have announced a partnership to establish Sagesse Bio, Inc., a joint venture poised to transform the aesthetic medicine industry. Sagesse Bio will harness the power of RNAi therapeutics to develop innovative products for body contouring and fat reduction. The partnership combines Sirnaomics’ expertise in […]

AusperBio secures USD 37Mln in series A financing

AusperBio Secures $37 Million in Series A Financing to Advance AHB-137 Clinical Development for HBV Cure

AusperBio Therapeutics, Inc. and Ausper Biopharma Co., Ltd. (collectively AusperBio), a privately held clinical-stage biotechnology company dedicated to advancing targeted oligonucleotide therapies, with the goal of achieving functional cure for chronic hepatitis B (CHB) infection, yesterday announced the completion of a $37 million Series A financing round. This round was led by existing investor, InnoPinnacle Fund, with participation from new […]

CycleØ announces acquisition of Biogasclean

CycleØ acquires Biogasclean to increase fully circular green gas production by capturing CO₂ 

CycleØ Group Limited today announces its acquisition of Biogasclean, a leading Danish supplier of biological methanation and desulphurisation systems. A prominent, pan-European biomethane platform, CycleØ develops, builds, owns and operates renewable natural gas (RNG) projects in Europe and Latin America.  Ara Partners, a private equity and infrastructure investment firm at the forefront of industrial decarbonisation, provided additional […]

CG Life adds Chris Weber as SVP of strategy

Chris Weber, Senior Vice President of Strategy, CG Life

CG Life, a leading integrated agency that blends strategic creative, marketing, digital, and communications with science, has welcomed Chris Weber as the agency’s Senior Vice President of Strategy. Weber brings three decades of healthcare agency experience to the role, where he will be responsible for broadening CG Life’s strategic offering and working closely with clients, especially those […]

Bristol Myers Squibb acquires Karuna Therapeutics

Bristol Myers Squibb Strengthens Neuroscience Portfolio with Acquisition of Karuna Therapeutics

Bristol Myers Squibb and Karuna Therapeutics, Inc. recently announced that they have entered into a definitive merger agreement under which Bristol Myers Squibb has agreed to acquire Karuna for $330.00 per share in cash, for a total equity value of $14.0 billion, or $12.7 billion net of estimated cash acquired. The transaction was unanimously approved […]

Ligandal Inc. Appoints Tushar Nuwal for two leadership roles

Tushar Nuwal, Chief Operating Officer and Chief Business Officer Ligandal Inc.

Ligandal Inc., an early-stage genetic medicine biotechnology company, announces the appointment of Tushar Nuwal as Chief Operating Officer and Chief Business Officer. Mr. Nuwal brings 20 years of biopharmaceutical experience, including roles at small and large pharmaceutical companies.  “We are elated to welcome Tushar to Ligandal. His experience in negotiating multi-billion-dollar pharmaceutical transactions and his […]

Massive Bio and CureMatch Partner to provide AI powered cancer treatment

Massive Bio and CureMatch announce groundbreaking partnership accessibility to Revolutionize Cancer Treatment through AI and Clinical Trial

Massive Bio, an AI-powered platform connecting patients with clinical trials and CureMatch, a healthcare technology company leveraging Knowledge Representation & Reasoning (KRR) AI for precision medicine support for oncology, and have announced a transformative partnership aimed at revolutionizing cancer treatment through advanced genomics, artificial intelligence, and expansive clinical trial accessibility. Massive Bio and CureMatch will leverage […]

Pharmatech Associates names Sireesha Yadlapalli as CEO

Sireesha Yadlapalli as Chief Executive Officer, Pharmatech

The Board of Directors of Pharmatech Associates yesterday announced the appointment of Sireesha Yadlapalli as chief executive officer, effective June 5, 2023. Ms. Yadlapalli will succeed Bikash Chatterjee, who will remain with the organization as President and chief science officer. Yadlapalli brings industry and regulatory experience to Pharmatech gained during her over 20-year career in the […]

Acurex Biosciences welcomes Dr. Robert Booth to its Board of Directors

Acurex Biosciences Corporation, a biopharmaceutical company with a mission to stop neurodegeneration before it begins, announces the appointment of renowned biopharmaceutical industry leader Dr. Robert Booth to its Board of Directors. Dr. Booth, distinguished for his invaluable contributions to the biopharmaceutical industry, brings over 30 years of experience in drug discovery, development, and executive leadership. […]